SCHEMBL6337049

SCHEMBL6337049

O=CCOc1ccccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.59
JAK2 O60674 1/20 0.59
LMNA P02545 1/20 0.59
MAPT P10636 1/20 0.59
CTSL P07711 1/20 0.49
CTSS P25774 1/20 0.49
CTSK P43235 1/20 0.49
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
DRD3 P35462 1/20 0.47
APP P05067 1/20 0.47
TSHR P16473 2/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HPGD P15428 3/20 0.45
ATM Q13315 1/20 0.45
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11063450 0.83 MAPT (0.41) GAAJAK2LMNAMAPTCTSL
SCHEMBL9694792 0.82 GAA (0.64) GAAJAK2LMNAMAPTDRD2
SCHEMBL11470280 0.80 GAA (0.62) GAAJAK2LMNAMAPTDRD2
1-Hydroxy-2-Allyloxybenzene SCHEMBL1562951 0.78 GAA (0.59) GAAJAK2LMNAMAPTAPP
SCHEMBL8968814 0.78 GAA (0.59) GAAJAK2LMNAMAPTDRD2
SCHEMBL514349 0.77 CTSL (0.47) LMNAMAPTCTSLCTSSCTSK
SCHEMBL10509104 0.77 LIG1 (0.53) LMNAMAPTCTSLCTSSCTSK
SCHEMBL3946342 0.77 L3MBTL1 (0.53) GAALMNAMAPTCTSLCTSS
SCHEMBL5004142 0.77 CTSS (0.47) LMNAMAPTCTSLCTSSCTSK
SCHEMBL5393569 0.77 CTSS (0.47) GAAJAK2LMNAMAPTCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020168609-A1 DENTAL GLUE, GLUE INJECTOR, AND DEVICE FOR DETECTING INJECTED GLUE KUSANO KAZUNORI (JP) 2002-11-14 US claimed
US-20020045148-A1 Paste formulation for dental use, a paste injector, and a system for detecting of paste filling KUSANO KAZUNORI (JP) 2002-04-18 US claimed
EP-1027876-A1 DENTAL GLUE, GLUE INJECTOR, AND DEVICE FOR DETECTING INJECTED GLUE Kusano, Kazunori (JP) 2000-08-16 EP claimed
CN-114292167-B Preparation method of vanillin 万华化学集团股份有限公司 2023-12-19 CN disclosed
CN-114292167-A Preparation method of vanillin 万华化学集团股份有限公司 2022-04-08 CN disclosed
CN-108636423-B Preparation method and application of supported nano-gold catalyst 云南大学 2021-01-15 CN disclosed
CN-108636423-A A kind of preparation method of load type nano gold catalyst and application 云南大学 2018-10-12 CN disclosed
US-8017803-B2 Process for the preparation of tamsulosin and intermediates thereof HOVIONE INTER LTD. (CH) 2011-09-13 US disclosed
US-20090234154-A1 Process for the preparation of tamsulosin and intermediates thereof HOVIONE INTER LTD. 2009-09-17 US disclosed
US-20050282116-A1 Root canal restoration dental material and a paste formulation for root canal restoration KUSANO KAZUNORI 2005-12-22 US disclosed
US-6537068-B2 Dental glue, glue injector, and device for detecting injected glue KUSANO KAZUNORI (JP) 2003-03-25 US disclosed
US-6508647-B2 Paste formulation for dental use, a paste injector, and a system for detecting of paste filling KUSANO KAZUNORI (JP) 2003-01-21 US disclosed
US-20020168609-A1 DENTAL GLUE, GLUE INJECTOR, AND DEVICE FOR DETECTING INJECTED GLUE KUSANO KAZUNORI (JP) 2002-11-14 US disclosed
US-20020045148-A1 Paste formulation for dental use, a paste injector, and a system for detecting of paste filling KUSANO KAZUNORI (JP) 2002-04-18 US disclosed
EP-1027876-A1 DENTAL GLUE, GLUE INJECTOR, AND DEVICE FOR DETECTING INJECTED GLUE Kusano, Kazunori (JP) 2000-08-16 EP disclosed
US-4351962-A Process for the preparation of hydroxy benzene carboxaldehydes RHONE POULENC INC. (US) 1982-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090234154-A1 Process for the preparation of tamsulosin and intermediates thereof AVPR2, AVPR1B, TACR2 GAA 2047/4885JAK2 1424/4885LMNA 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.